New Gastrointestinal Symptoms Are Common in Inflammatory Bowel Disease Patients With COVID-19: Data From an International Registry

Creator

Ungaro, Ryan C
- Other Affiliation: Icahn School of Medicine at Mount Sinai
Agrawal, Manasi
- Other Affiliation: Icahn School of Medicine at Mount Sinai
Brenner, Erica J
- Affiliation: School of Medicine, Department of Pediatrics
Zhang, Xian
- Affiliation: School of Medicine, Department of Pediatrics
Colombel, Jean-Frederic
- Other Affiliation: Icahn School of Medicine at Mount Sinai
Kappelman, Michael D
- Affiliation: School of Medicine, Department of Pediatrics
Reinisch, Walter
- Other Affiliation: Medical University of Vienna

Abstract

Coronavirus disease 2019 (COVID-19) can cause gastrointestinal (GI) symptoms. A prior meta-analysis suggested that up to 17.6% of COVID-19 patients have GI symptoms. Data are conflicting on the association of GI symptoms with COVID-19 outcomes, with some reports suggesting worse prognosis among those with GI symptoms while others finding improved outcomes. There are limited data on COVID-19 and GI symptoms among inflammatory bowel disease (IBD) patients. A single-center study of 80 IBD patients with COVID-19 observed that they were more likely to present with abdominal pain and diarrhea than non-IBD controls. In addition, a prior systematic review on just over 400 patients found nearly one-quarter of IBD patients with COVID-19 had diarrhea.6 Using a large, international database, we aimed to describe new onset GI symptoms and their association with clinical outcomes in patients with IBD who develop COVID-19.

Date of publication

Keyword

DOI

Identifier

Resource type

Rights statement

Journal title

Journal issue

Language

ISSN

Relations

Parents:

This work has no parents.

In Collection:

Thumbnail	Title	Date Uploaded	Visibility	Actions
	izab184.pdf	2021-08-02	Public	Download